Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...
Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable private ...
Investors can apply for a minimum of 200 shares and its multiples thereafter. The IPO of Zinka Logistics includes a fresh shares sale of Rs 550 crore, while shareholders and promoters will offload ...
But, what is emboldening the startups to revisit their IPO plans, a year after many of them shelved or postponed their plans? The answer is the thawing funding winter, a renewed push for ...
BioAge Labs (BIOA) announced that it will present new preclinical data for its lead product candidate azelaprag, an orally available small ...
SINGAPORE: The retail offering for the initial public offering (IPO) of Malaysia’s top mini-market chain 99 Speed Mart Retail Holdings has been oversubscribed by 3.04 times, the issue’s ...
KUALA LUMPUR: The public issue of Kucingko Bhd’s initial public offering (IPO) of 25 million shares made available for the public has been oversubscribed 99.02 times. In a statement, the ...
This page features the latest news about the Bioage Labs stock. BioAge Labs director Enright buys $7.2 million in stock BioAge Labs, Inc. (NASDAQ:BIOA) has seen significant insider activity as ...
Afcons Infrastructure IPO listing date is today, November 4, 2024. Stock market analysts and the trends in Afcons Infrastructure IPO GMP ahead of share listing indicate a flat debut of shares today.
According to a prospectus on the IPO, Zenas ended the second quarter with around $184 million in cash and has earmarked most of the IPO proceeds for obexelimab's clinical trials programme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback